胸外科数据库分析:淋巴结清扫与乳糜胸的关联
基于STS胸外科数据库152,823例I–III期非小细胞肺癌择期肺切除患者,30天乳糜胸发生率为0.73%(n=1110)。乳糜胸组清扫淋巴结中位数更高(14 vs 10),右侧肿瘤占78.4% vs 60.9%,乳糜胸与主要并发症率升高相关(35.7% vs 6.6%,P<.001)但未增加死亡率(1.4% vs 1.0%,P=.17)。
要点
- 乳糜胸风险随淋巴结清扫数目增加而升高
- 右侧肿瘤、cT4、透析、开放手术为独立预测因素
- 乳糜胸显著增加主要并发症率但不增加死亡率
核心结论
- 乳糜胸风险随清扫淋巴结数目增加而升高,并与主要并发症率大幅升高相关,但不增加死亡率。
- 在低级别癌症患者中,需权衡广泛淋巴结清扫的肿瘤学获益与其带来的乳糜胸等风险。
研究设计与样本
- 主要终点为术后30天乳糜胸,采用多变量logistic回归识别独立预测因素,并使用2021年至今数据做敏感性分析评估淋巴结站与乳糜胸的关系。
主要发现
- 总体乳糜胸发生率为0.73%(n=1110)。
- 乳糜胸组淋巴结清扫中位数为14(IQR 9–21),非乳糜胸组为10(IQR 6–16)。
- 乳糜胸组右侧肿瘤比例更高(78.4% vs 60.9%)。
- 乳糜胸与主要并发症率升高相关(35.7% vs 6.6%,P<.001),但死亡率无显著差异(1.4% vs 1.0%,P=.17)。
关键数值与推荐
- 乳糜胸独立预测因素:清扫淋巴结数目、cT4(aOR 4.72;95%CI 1.13–19.63)、右侧肿瘤(aOR 2.17;95%CI 1.83–2.59)、透析(aOR 2.15;95%CI 1.49–3.11)、开放手术(aOR 1.59;95%CI 1.34–1.88)。
- 敏感性分析额外识别2R站采样为独立预测因素(aOR 1.27;95%CI 1.02–1.57)。
临床怎么用
- 对低级别癌症患者制定淋巴结清扫范围时,应权衡肿瘤学获益与乳糜胸风险。
- 右侧肿瘤、cT4、透析及开放手术患者应关注乳糜胸风险,尤其当清扫淋巴结数目较多或涉及2R站采样时。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Guideline-concordant lymph node (LN) dissection may increase chylothorax risk after lung resection. We analyzed predictors of chylothorax, with a focus on the extent and pattern of LN dissection, using The Society of Thoracic Surgeons General Thoracic Surgery Database. METHODS: We studied patients who underwent elective lung resection for stage I to III non-small cell lung cancer from January 2015 to December 2024 (N = 152,823). The primary end point was 30-day postoperative chylothorax. Independent predictors of chylothorax were identified using multivariable logistic regression. A sensitivity analysis assessed nodal stations and chylothorax using contemporary data (2021-present). RESULTS: The overall incidence of chylothorax was 0.73% (n = 1110). Patients with chylothorax were younger, had fewer comorbidities, a higher frequency of right-sided tumors (78.4% vs 60.9%), and more advanced disease. The median number of LNs dissected was higher in the chylothorax group (14 [interquartile range, 9-21] vs 10 [interquartile range, 6-16]). The strongest independent predictors of chylothorax included the number of sampled LNs, cT4 (adjusted odds ratio [aOR], 4.72; 95% CI, 1.13-19.63), right-sided tumor (aOR, 2.17; 95% CI, 1.83-2.59), dialysis (aOR, 2.15; 95% CI, 1.49-3.11), and open surgical approach (aOR, 1.59; 95% CI, 1.34-1.88). Sensitivity analyses confirmed these findings and identified 2R sampling as an additional independent predictor (aOR, 1.27; 95% CI, 1.02-1.57). Chylothorax was associated with a higher rate of major morbidity (35.7% vs 6.6%, P < .001) but not increased mortality (1.4% vs 1.0%, P = .17). CONCLUSIONS: Chylothorax risk increases with the number of LNs dissected and is associated with a dramatic increase in morbidity but not mortality. This underscores the importance of balancing the oncologic benefit of extensive LN dissection in patients with low-grade cancers against the risks it poses, including chylothorax.
引用
- Kamtam DN, Bonnell LN, Kapula N, et al. A Society of Thoracic Surgeons General Thoracic Surgery Database Analysis of the Association Between Lymph Node Dissection and Chylothorax. Ann Thorac Surg. 2026. PMID: 42034239. doi:10.1016/j.athoracsur.2026.04.013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。